amoxycillin probenecid versu doxycyclin treatment erythema migran borreliosi adult erythema migran earli lyme borreliosi randomis prospect trial amoxycillin mg probenecid mg time day doxycyclin mg day day antibiot regimen in-vitro sensit borrelia burgdorferi antibiot tissu penetr pharmacokinet drug organ earli cours infect patient evalu doxycyclin group amoxycillin/probenecid group regimen effect treatment erythema migran mild fatigu arthralgia post-treat complaint month none patient antibiot treatment lyme borreliosi 